3[1]Fujil S, Kameyama K, Husone M et al. Effect of cilnidipine, a novel dihydropyridine Ca2 + -channel antagonist, on N-type Ca2 + channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther, 1997;280(3) : 1184
4[2]Minami J, Ishimitsu T, Kawano Y et al. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hy pertensive patients treated with cilnidipine or nifedipine retard. J Cardiovasc Pharmacol, 1998;32(2) :331
5[3]Saihara S, Sumio M, HosonoMetal. Effect of FRC 8653 (cilni dipine) on blood pressure changes during the cold pressor test. J pn Pharmacol Ther , 1993;21(suppl):271
6[4]Yoshimoto R, Hashiguchi Y, Dohmoto H et al. Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in con scious spontaneously hypertensive rats. J Pharmacobiodyn, 1992;15:25
7[5]Ikeda K, Honoso M, Iida H et al. Antihypertensive and cardio vascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl(E)-3-phenyl-2-propen-1yl( ± ) 1,4 dihydro 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5 dicarboxylate ( FRC-8653). Pharmacometrics, 1992;44:433
8[6]Hisayuki U, Hirohisa U ,Tomoyuki K et al. CilnIdipine: pre clinical profile and clinical evaluation. Cardovascular Drug Re views, 1999;17:341
9[7]Watanable K, Hosono M, Hayashi Y. Hypotensive effect of in travenous administration of cilnidipine (FRC 8653) in conscious spontaneously hypertensive rats. Jpn Pharmacol Ther, 1995; 23:3201～7
10[8]Hosono M, Dozen M, Hiruma T et al. Change in heart rate and plasma norepinephrine level of conscious spontaneously hyperten sive rats treated with cilnidipine (FRC-8653). Jpn Pharmacol Ther , 1995;23:3029
